文献速递免疫规划卫生政策与健康促进

及时性在老年人疫苗接种成本效果中的作用:澳大利亚肺炎球菌结合疫苗案例研究

The role of timeliness in the cost-effectiveness of older adult vaccination: A case study of pneumococcal conjugate vaccine in Australia.
PubMed 文献 · Vaccine · 2018-02-01

研究构建多队列马尔可夫模型,评估澳大利亚肺炎球菌(PCV13)免疫规划在两种接种率建模方式下的成本效果。一种采用观察到的接种率分布,另一种假设累计接种量均在推荐年龄完成。两种方式在预防病例数和成本效果上结果不同。非及时接种的影响可能为正也可能为负,取决于年龄别疾病率和疫苗保护持续时间等因素。

要点

  • 两种接种率建模方式在预防病例数和成本效果上产生不同结果。
  • 非及时接种对成人项目的影响可能为正也可能为负。
  • 影响方向取决于年龄别疾病率和疫苗保护持续时间等因素。

核心结论

  • 使用更接近实际的观察接种率分布(考虑65岁后年龄增长带来的疫苗效力降低和肺炎球菌疾病负担升高)会影响成本效果评估结果。
  • 非及时接种对成人项目的影响有时为正、有时为负,取决于年龄别疾病率和疫苗保护持续时间等因素。
  • 研究强调在估计成人疫苗接种影响时应使用围绕接种率的现实假设(包括非及时接种)。

研究设计与样本

  • 构建多队列马尔可夫模型,评估澳大利亚肺炎球菌(PCV13)免疫规划的成本效果。
  • 模型假设两种不同的接种率建模方式:一种使用观察到的接种率估计,另一种假设总累计接种量在推荐年龄完成。
  • 模型考虑65岁后年龄增长伴随的疫苗效力降低和肺炎球菌疾病负担升高。

主要发现

  • 两种接种率建模方式在预防病例数和成本效果上均产生不同结果。
  • 非及时接种对成人项目的影响可能为正也可能为负,取决于年龄别疾病率和疫苗保护持续时间等因素。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

While the impact of the timeliness of vaccine administration has been well-studied for childhood vaccinations, there has been little detailed quantitative analysis on the potential impact of the timeliness of vaccinations in older adults. The aim of this study was to explore the impact of implementing more realistic observed uptake distributions, taking into the account reduced vaccine efficacy but higher pneumococcal disease burden with increasing age beyond 65 years. A multi-cohort Markov model was constructed to evaluate the cost-effectiveness of a pneumococcal (PCV13) immunisation program in Australia, assuming two different uptake modelling approaches. The approach using an estimate of observed uptake was compared with a scenario in which the total cumulative uptake was delivered at the recommended age of vaccination. We found these two approaches produced different results both in terms of cases prevented and cost-effectiveness. The impact of the non-timely uptake in adult programs may sometimes have positive and other times negative effects, depending on several factors including the age-specific disease rates and the duration of vaccine protection. Our study highlights the importance of using realistic assumptions around uptake (including non-timely vaccination) when estimating the impact of vaccination in adults.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Chen C, Wood JG, Beutels P, et al. The role of timeliness in the cost-effectiveness of older adult vaccination: A case study of pneumococcal conjugate vaccine in Australia. Vaccine. 2018. PMID: 29395534. doi:10.1016/j.vaccine.2018.01.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。